MAPT and supranuclear palsy, progressive, 1: Since the abnormal accumulation of tau proteins within brain cells is considered a potential target for developing therapeutic interventions for PSP, the predominant studies on CSF biomarkers for PSP were focused on tau proteins [9–11].